Molecular Partners Ag MOLN
NASDAQ MOLN
$4.40 +0.17 (+4.02%)
As of: Aug 21, 2026 · 12:43 PM EDT

Molecular Partners Ag (MOLN) Change in Account Payables (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Change in Account Payables of $192.83 for Q1 2026, down 75.09% year-over-year from $774.13 in Q1 2025, and down 99.76% quarter-over-quarter from $80794.3 in Q4 2025.

Molecular Partners Ag (MOLN) Change in Account Payables (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Change in Account Payables for 7 consecutive years, with $192.83 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Account Payables fell 75.09% year-over-year to $192.83; the TTM figure through Mar 2026 stood at $69236.3 (down 86.74% YoY), while the FY2025 annual figure was $81326.0, down 86.4% from the prior year.
  • Change in Account Payables eased to $192.83 in Q1 2026 per MOLN's latest filing, from $80794.3 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.9 million in Q3 2022 and bottomed at -$5.5 million in Q4 2022.
  • Historically, Change in Account Payables has averaged -$345940.2 across 5 years, with a median of $773.03 in 2023.
  • Annual changes were most pronounced in 2022 — Change in Account Payables slumped 407.97% — and 2024, when it jumped 174.63%.
  • Molecular Partners Ag's Change in Account Payables stood at -$5.5 million in 2022, then soared by 83.47% to -$915352.1 in 2023, then surged by 165.22% to $596955.4 in 2024, then plunged by 86.47% to $80794.3 in 2025, then sank by 99.76% to $192.83 in 2026.
  • Business Quant data shows MOLN's Change in Account Payables at $192.83 in Q1 2026, $80794.3 in Q4 2025, and -$338248.4 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Molecular Partners Ag 163.99 Mn 163.99 Mn - 192.83

Historic Data

Download Data
DateValue
Mar 31, 2026 192.83
Mar 31, 2026 192.83
Dec 31, 2025 80,794.29
Dec 31, 2025 80,794.29
Sep 30, 2025 -338,248.38
Sep 30, 2025 -338,248.38
Jun 30, 2025 326,497.56
Jun 30, 2025 326,497.56
Mar 31, 2025 774.13
Mar 31, 2025 774.13
Dec 31, 2024 596,955.43
Dec 31, 2024 596,955.43
Sep 30, 2024 -1.78 Mn
Sep 30, 2024 -1.78 Mn
Jun 30, 2024 1.70 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 2,122.95
Mar 31, 2024 2,122.95
Dec 31, 2023 -915,352.08
Dec 31, 2023 -915,352.08